LINC01405 Gene

Name long intergenic non-protein coding RNA 1405
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n LINC01405 is a long non‐coding RNA that has emerged as a notable player in diverse disease contexts. In the setting of HER‐2–enriched breast cancer, high‐throughput transcriptome analysis identified LINC01405 among a set of dysregulated lncRNAs, with coexpression network analysis highlighting it as one of the core genes potentially involved in regulating key oncogenic pathways such as MAPK signaling, PI3K–Akt signaling, metabolic processes, cell cycle progression, and actin cytoskeleton dynamics."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In another study addressing skeletal muscle dysfunction in chronic obstructive pulmonary disease, LINC01405 was found to be among the transcripts exhibiting at least a twofold change, suggesting that its dysregulation might contribute to the molecular remodeling underlying quadriceps muscle impairment in these patients."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Furthermore, in tongue squamous cell carcinoma, LINC01405 was identified as one of several pivotal lncRNAs with aberrant expression profiles. Its potential role as a prognostic marker in TSCC underscores its importance and warrants further investigation into its mechanistic contributions to tumor pathogenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Collectively, these studies implicate LINC01405 in the regulation of critical signaling networks in cancer and possibly in the context of muscle dysfunction associated with chronic disease, highlighting its potential as both a biomarker and a therapeutic target.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Fan Yang, Shixu Lyu, Siyang Dong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression profile analysis of long noncoding RNA in HER-2-enriched subtype breast cancer by next-generation sequencing and bioinformatics."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Onco Targets Ther (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2147/OTT.S97664"}], "href": "https://doi.org/10.2147/OTT.S97664"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26929647"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26929647"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Saffron A G Willis-Owen, Anna Thompson, Paul R Kemp, et al. "}, {"type": "b", "children": [{"type": "t", "text": "COPD is accompanied by co-ordinated transcriptional perturbation in the quadriceps affecting the mitochondria and extracellular matrix."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-018-29789-6"}], "href": "https://doi.org/10.1038/s41598-018-29789-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30111857"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30111857"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Mi Zhang, Zexi Chen, Sihui Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of Differentially Expressed Long Non-coding RNAs and the Associated TF-mRNA Network in Tongue Squamous Cell Carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Oncol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fonc.2020.01421"}], "href": "https://doi.org/10.3389/fonc.2020.01421"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32923393"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32923393"}]}]}]}
NCBI Gene ID 100131138
API
Download Associations
Predicted Functions View LINC01405's ARCHS4 Predicted Functions.
Co-expressed Genes View LINC01405's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View LINC01405's ARCHS4 Predicted Functions.

Functional Associations

LINC01405 has 292 functional associations with biological entities spanning 2 categories (cell line, cell type or tissue, gene, protein or microRNA) extracted from 5 datasets.

Click the + buttons to view associations for LINC01405 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of LINC01405 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of LINC01405 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of LINC01405 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of LINC01405 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of LINC01405 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.